Stock listing
OTC:SANW S&W Seed Company Stock
Follow S&W Seed Company into a list and get an email when it puts out news.
Share price · OTC:SANW
$0.0002 USD 0.0000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.0002 – $0.0002 USDNov 20, 2026
- Volume
- 1,000 sharesNov 20, 2026
- Market cap
- $429 USDAt the close on Nov 20, 2026 · price × 2.15M shares outstanding

Daily closes
Last 3 months, Oct 15, 2026 – Nov 20, 2026 · OTC:SANW · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 1,000 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 654 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 797 | |
| $0.0002 | 0.0000 | 0.0% | $0.0002 | $0.0002 | $0.0002 | 107 | |
| $0.0002 | -0.0003 | -60.0% | $0.0002 | $0.0002 | $0.0002 | 3,882 | |
| $0.0005 | 0.0000 | 0.0% | $0.0005 | $0.0005 | $0.0005 | 367 | |
| $0.0005 | +0.0003 | +150.0% | $0.0005 | $0.0005 | $0.0005 | 4,565 | |
| $0.0002 | — | — | $0.0002 | $0.0002 | $0.0002 | 358 |
Splits
1 split · OTC:SANW · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-19 | Consolidation |
- Ticker
- OTC:SANW
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
S&W Seed Company on 6ix
- Calls
- 18 calls with a replay · 18 with a transcript · latest May 15, 2025
- Decks
- 12 decks · latest March 2024
Events
Calls
| Call | When | Status |
|---|---|---|
| S&W Seed (OTC:SANW) Q3 2025 Earnings Call | Thu, May 15, 2025 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q2 2025 Earnings Call | Thu, Feb 13, 2025 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q1 2025 Earnings Call | Tue, Nov 19, 2024 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q4 2024 Earnings Call | Fri, Nov 01, 2024 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q3 2024 Earnings Call | Tue, May 14, 2024 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q2 2024 Earnings Call | Wed, Feb 14, 2024 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q1 2024 Earnings Call | Thu, Nov 09, 2023 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q4 2023 Earnings Call | Wed, Sep 27, 2023 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q3 2023 Earnings Call | Thu, May 11, 2023 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q2 2023 Earnings Call | Mon, Feb 13, 2023 · 11:00 AM ET | Replay |
All 18 calls
| Call | When | Status |
|---|---|---|
| S&W Seed (OTC:SANW) Q1 2023 Earnings Call | Mon, Nov 14, 2022 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q4 2022 Earnings Call | Wed, Sep 28, 2022 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q3 2022 Earnings Call | Mon, May 16, 2022 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q2 2022 Earnings Call | Thu, Feb 10, 2022 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q1 2022 Earnings Call | Thu, Nov 11, 2021 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q4 2021 Earnings Call | Mon, Sep 27, 2021 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q3 2021 Earnings Call | Thu, May 13, 2021 · 11:00 AM ET | Replay |
| S&W Seed (OTC:SANW) Q2 2021 Earnings Call | Thu, Feb 11, 2021 · 11:00 AM ET | Replay |
Results days
| Quarter | Results |
|---|---|
| Q3 2025 | May 15, 2025 · Before open |
| Q2 2025 | Feb 13, 2025 · Before open |
| Q1 2025 | Nov 1, 2024 · Before open |
| Q4 2024 | Sep 25, 2024 |
| Q3 2024 | May 14, 2024 · Before open |
| Q2 2024 | Feb 14, 2024 · Before open |
| Q1 2024 | Nov 9, 2023 · Before open |
| Q4 2023 | Sep 27, 2023 · Before open |
| Q3 2023 | May 11, 2023 · Before open |
| Q2 2023 | Feb 13, 2023 · Before open |
All 18 quarters
| Quarter | Results |
|---|---|
| Q1 2023 | Nov 14, 2022 · Before open |
| Q4 2022 | Sep 28, 2022 · Before open |
| Q3 2022 | May 16, 2022 · Before open |
| Q2 2022 | Feb 10, 2022 · Before open |
| Q1 2022 | Nov 11, 2021 · Before open |
| Q4 2021 | Sep 27, 2021 · Before open |
| Q3 2021 | May 13, 2021 · Before open |
| Q2 2021 | Feb 11, 2021 · Before open |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2024) | Investor deck | 38 slides | March 2024 |
| Investor Presentation (May 2023) | Investor deck | 27 slides | May 2023 |
| Investor Presentation (March 2023) | Investor deck | 28 slides | Mar 13, 2023 |
| Investor Presentation (March 2021) | Investor deck | 30 slides | March 2021 |
| Investor Presentation (December 2020) | Investor deck | 41 slides | December 2020 |
| Investor Presentation (October 2020) | Investor deck | 36 slides | October 2020 |
| Investor Presentation (March 2020) | Investor deck | 44 slides | March 2020 |
| Merger or Acquisition (February 2020) | Merger or acquisition | 11 slides | February 2020 |
| Investor Presentation (February 2019) | Investor deck | 29 slides | February 2019 |
| Merger or Acquisition (November 2018) | Merger or acquisition | 17 slides | November 2018 |
All 12 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (June 2017) | Investor deck | 46 slides | June 2017 |
| Investor Presentation (May 2015) | Investor deck | 42 slides | May 2015 |
Financials
Annual, in USD
Income statement
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 60.4M | 73.5M | 71.4M | 84.0M | 79.6M | 109.7M | 64.1M | 75.4M | 96.0M | 81.2M |
| Cost of revenue | 44.6M | 59.0M | 65.0M | 70.4M | 64.6M | 69.0M | 49.3M | 59.2M | 77.7M | 64.6M |
| Gross profit | 15.8M | 14.5M | 6.36M | 13.7M | 14.9M | 40.7M | 14.8M | 16.1M | 18.4M | 16.6M |
| Research and development | 4.06M | 5.24M | 7.71M | 8.52M | 7.34M | 6.27M | 3.89M | 3.03M | 2.76M | 1.89M |
| Selling, general and administrative | 21.7M | 22.4M | 24.5M | 21.9M | 21.3M | 17.5M | 10.5M | 11.8M | 10.4M | 9.62M |
| Operating income | -17.7M | -17.9M | -32.8M | -20.3M | -16.8M | 11.4M | -2.99M | -2.41M | 2.04M | 2.39M |
| Depreciation and amortization | 4.29M | 4.77M | 5.46M | 5.47M | 5.04M | 4.13M | 3.44M | 3.33M | 3.19M | 2.18M |
| EBITDA | -13.4M | -13.2M | -27.3M | -14.8M | -11.8M | 15.6M | 445.7K | 917.3K | 5.23M | 4.57M |
| Interest expense | 7.40M | 6.16M | 3.23M | 2.97M | 2.53M | 3.23M | 2.03M | 2.50M | 5.99M | 4.77M |
| Income before tax | -29.6M | 13.7M | -35.9M | -19.1M | -19.4M | -9.50M | -4.58M | -4.19M | -2.04M | -4.01M |
| Income tax | 496.3K | -763.6K | 413.4K | -24.4K | 386.0K | -148.7K | 143.0K | 7.63M | -2.40M | -846.0K |
| Net income | -30.0M | 14.4M | -36.3M | -19.1M | -19.7M | -9.35M | -4.73M | -11.8M | 365.2K | -3.16M |
| Earnings per share, basic | -13.21 | 6.71 | -18.56 | -11.05 | -11.84 | -6.21 | -4.20 | -13.34 | 0.49 | -0.24 |
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 294.0K | 3.40M | 2.06M | 3.53M | 4.12M | 3.43M | 4.32M | 745.0K | 6.90M | 3.54M |
| Short-term investments | 0 | 0 | 0 | 0 | ||||||
| Receivables | 20.9M | 31.5M | 19.1M | 19.4M | 19.0M | 13.4M | 13.9M | 23.2M | 27.6M | 26.7M |
| Inventory | 38.1M | 45.1M | 54.5M | 63.4M | 63.9M | 71.3M | 60.4M | 31.5M | 21.8M | 25.5M |
| Current assets | 63.4M | 84.1M | 77.2M | 87.9M | 88.4M | 91.6M | 79.9M | 56.7M | 57.6M | 56.9M |
| Property, plant and equipment | 29.6M | 21.9M | 17.7M | 25.8M | 20.6M | 13.2M | 13.6M | 12.6M | 11.5M | |
| Goodwill | 20.3M | 8.08M | 0 | 1.65M | 1.51M | 32.7M | 10.3M | 10.3M | 10.3M | 9.63M |
| Total assets | 120.7M | 152.0M | 133.8M | 151.5M | 156.0M | 146.4M | 137.8M | 117.1M | 127.0M | 122.3M |
| Accounts payable | 13.5M | 13.3M | 15.9M | 15.9M | 8.05M | 6.93M | 5.94M | 7.49M | 14.7M | 14.9M |
| Current liabilities | 69.2M | 71.3M | 48.3M | 61.1M | 52.6M | 33.9M | 42.4M | 51.3M | 41.4M | 42.5M |
| Long-term debt | 4.42M | 4.50M | 25.2M | 10.5M | 12.7M | 10.5M | 13.0M | 1.10M | 11.1M | 21.6M |
| Total debt | 54.3M | 56.5M | 51.1M | 47.2M | 43.1M | 24.0M | 46.1M | 38.8M | 34.9M | 46.9M |
| Total liabilities | 75.7M | 77.9M | 82.4M | 77.1M | 74.6M | 46.4M | 56.0M | 55.9M | 59.2M | 70.5M |
| Shareholders' equity | 45.0M | 68.8M | 51.4M | 74.4M | 81.5M | 100.0M | 81.7M | 61.2M | 67.8M | 51.9M |
| Shares outstanding | 2.27M | 2.15M | 1.96M | 1.73M | 1.67M | 1.51M | 1.12M | 885.9K | 746.8K | 13.3M |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -5.64M | -19.0M | -18.4M | -14.2M | -5.76M | 21.3M | -22.2M | -10.3M | 6.71M | 11.1M |
| Capital spending | -1.54M | -1.03M | -2.10M | -1.08M | -1.97M | -778.3K | -1.48M | -3.12M | -2.61M | -1.60M |
| Free cash flow | -7.18M | -20.0M | -20.5M | -15.3M | -7.74M | 20.5M | -23.7M | -13.4M | 4.10M | 9.52M |
| Cash from investing | 5.88M | 8.37M | -909.4K | 2.47M | -10.3M | -26.6M | -1.44M | -2.24M | -3.88M | -31.2M |
| Cash from financing | -3.35M | 11.9M | 17.1M | 10.9M | 17.0M | 4.63M | 27.3M | 6.20M | 567.4K | 22.4M |
| Dividends paid | -82.2K | -192.5K | -111.5K | -39.3K | 0 | 0 | 0 | 0 | ||
| Share buybacks | -82.2K | -192.5K | -111.5K | -110.1K | -39.3K | 22.5M | -143.5K | 13.3M | 5.24M | |
| Change in cash | -3.10M | 1.34M | -1.47M | -595.2K | 691.3K | -889.1K | 3.58M | -6.16M | 3.37M | 2.37M |
Cap table
Built by 6ix from S&W Seed Company’s releases
- Common shares
- 2,146,806
- Fully diluted
- 2,146,806
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 2,146,806 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 2,146,806 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alexander Matina Other companies: Standard Nuclear, Inc. (Director · Since at least Jul 15, 2026); Range Capital Acquisition Corp II (Director · Since at least Oct 2, 2025); Nu Ride Inc (Chief Executive Officer, Director · Since at least Mar 14, 2024); Range Capital Acquisition Corp. (Director · Dec 19, 2024 – Dec 19, 2024 · Past); Trinity Place Holdings Inc. (Director · Nov 17, 2016 – Sep 17, 2024 · Past) | Director · Dec 16, 2016 – Dec 17, 2024 · Past |
| Matthew K Szot Other companies: Cadrenal Therapeutics, Inc. (Chief Financial Officer · Since at least Jan 19, 2023); INVO Fertility, Inc. (Director · Since at least Sep 13, 2020); SenesTech, Inc. (Director · Since at least Dec 18, 2017); Beeline Holdings, Inc. (Director · Jun 18, 2018 – Jun 30, 2019 · Past) | EVP Finance & Admin and CFO · Oct 1, 2017 – Oct 5, 2021 · Past |
| Ann M Veneman Other companies: Icosavax Inc (Director · Jul 28, 2021 – Jun 6, 2023 · Past); Alexion Pharmaceuticals Inc (Director · May 28, 2010 – Sep 5, 2017 · Past) | Director · Dec 10, 2013 – Dec 10, 2013 · Past |
| Consuelo E. Madere Other companies: Lindsay Corporation (Director · Since at least Feb 12, 2018); Monsanto (VP, Global Veg/Asia Commercial · Oct 24, 2011 – Jan 11, 2013 · Past) | Director · Jan 9, 2018 – Dec 15, 2021 · Past |
| Grover T Wickersham Other companies: SenesTech, Inc. (Director · Dec 7, 2016 – Jun 19, 2018 · Past); Beeline Holdings, Inc. (Chairman, CEO and President, Director · Sep 15, 2016 – Nov 21, 2018 · Past) | Director · May 3, 2010 – Jan 10, 2019 · Past |
| Mark Wong Other companies: Arcadia Biosciences, Inc. (Director · May 14, 2015 – Sep 9, 2015 · Past); Green Brick Partners, Inc. (Director · Jan 16, 2008 – Mar 15, 2012 · Past) | Director · Jun 30, 2015 – Dec 17, 2024 · Past |
| Mick Fleming Other companies: Beeline Holdings, Inc. (Director · Aug 31, 2016 – Jun 30, 2019 · Past); Jones Soda Co (Director · Mar 6, 2006 – Jan 3, 2022 · Past) | Director · May 3, 2010 – Oct 19, 2016 · Past |
| Robert D Straus Other companies: TechPrecision Corporation (Director · Since at least Dec 19, 2024); Nature's Sunshine Products, Inc. (Director · Since at least Jun 8, 2017) | Director · Jan 9, 2018 – Dec 15, 2021 · Past |
| Jeffrey A Rona Other companies: Ovid Therapeutics Inc. (CBFO · Since at least Sep 30, 2020) | Director · Dec 15, 2023 – Dec 17, 2024 · Past |
| Alan D Willits | Director · Jul 10, 2018 – Dec 17, 2024 · Past |
All 26 people
| Person | Seat |
|---|---|
| Charles B Seidler | Director · Jun 11, 2010 – Dec 15, 2021 · Past |
| Danielson B Gardner | Chief Marketing & Tech Officer · Oct 15, 2012 – Oct 7, 2018 · Past |
| Daniel Z Karsten | Vice President of Processing · May 3, 2010 – Mar 4, 2015 · Past |
| David A Fischhoff | Director · Dec 9, 2016 – Dec 15, 2021 · Past |
| David Thomas Callachor | Executive VP, International · Oct 29, 2018 – Oct 5, 2021 · Past |
| Dennis Charles Jury | EVP Operations and COO · Apr 1, 2013 – Oct 1, 2018 · Past |
| Donald M Panter Jr | Executive VP, Americas · Oct 29, 2018 – Apr 1, 2023 · Past |
| Elizabeth Horton | Director · Nov 15, 2021 – Dec 13, 2023 · Past |
| Fred G Fabre | VP of Sales and Marketing · Oct 1, 2012 – Dec 11, 2014 · Past |
| Mark Herrmann | President and CEO · Dec 14, 2022 – Mar 5, 2025 · Past |
| Mark James Harvey | Director · Apr 1, 2016 – Jul 1, 2024 · Past |
| Mark S Grewal | President and CEO, Director · May 3, 2010 – May 19, 2017 · Past |
| Michael C Culhane | Director · May 3, 2010 – Jan 31, 2014 · Past |
| Michael N Nordstrom | Director · May 20, 2013 – Mar 12, 2015 · Past |
| Vanessa Baughman | CHIEF FINANCIAL OFFICER · May 11, 2023 – Apr 1, 2025 · Past |
| William S Smith | Director · Jul 1, 2014 – Dec 11, 2015 · Past |
Log in to ask 6ix AI your own questions about S&W Seed Company.